Charles Ferte

Paris, FR 
Paris, FR 

Overview

Charles Ferte practices practicing medicine in Paris, France.

His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), Lung Adenocarcinoma, and Laryngectomy.

He is actively involved in clinical research, co-authoring 59 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Paris, France
Other Locations
Villejuif, 94805, France
Roussy-le-village, France
Lille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomised Phase II Study in Metastatic Pancreatic Cancer Evaluating FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem in First-line
Randomised Phase II Study in Metastatic Pancreatic Cancer Evaluating FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem in First-line
Enrollment Status: Completed
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: FOLFIRINOX, LV5FU2, FOLFIRI.3, Gemcitabine
Study Phase: Phase 2
Phase II Randomized Trial Evaluting Aflibercept Associated With LV5FU2 Regimen as First Line Treatment of Non-resectalbe Metastatic Colorectal Cancers
Phase II Randomized Trial Evaluting Aflibercept Associated With LV5FU2 Regimen as First Line Treatment of Non-resectalbe Metastatic Colorectal Cancers
Enrollment Status: Completed
Publish Date: July 10, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Clinical Trial to Investigate Biomarker Effects of Pre-Surgical Treatment With DDR Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Who Are Planned to Undergo Surgery That is Likely to be Followed by Radiotherapy and/or Chemotherapy.
A Clinical Trial to Investigate Biomarker Effects of Pre-Surgical Treatment With DDR Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Who Are Planned to Undergo Surgery That is Likely to be Followed by Radiotherapy and/or Chemotherapy.
Enrollment Status: Completed
Publish Date: August 10, 2021
Intervention Type: Drug
Study Drugs: Ceralasertib, Olaparib
Study Phase: Phase 1
View 2 Less Clinical Trials

59 Total Publications

Automated extraction of temporalized tumor evolution from oncology EMRs using natural language processing.
Automated extraction of temporalized tumor evolution from oncology EMRs using natural language processing.
Journal: ESMO real world data and digital oncology
Published: April 03, 2026

Frequently Asked Questions about Charles Ferte

Is Charles Ferte a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Charles Ferte is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Charles Ferte participate in research or clinical trials?

Yes. Charles Ferte has published 59 articles and abstracts on conditions like Lung Cancer. You can view a list of Charles Ferte's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ferte's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile